HDAX Therapeutics

About:

HDAC6, small molecule, peripheral neuropathy, cardiometabolic, pharmaceuticals, biotech, biopharma, life science

Twitter/X: hdaxtx

Top Investors: Ontario Centre of Innovation, FACIT, Anges Quebec, Toronto Innovation Acceleration Partners, Ontario Bioscience Industry Organization

Description:

HDAX Therapeutics is pioneering next-gen precision therapeutics for cardiovascular and neurological diseases by targeting their root causes to enhance patient outcomes.

Total Funding Amount:

4.8M CAD

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2021-08-10

Contact Email:

info(AT)hdaxtx.com

Founders:

Nabanita Nawar, Patrick T. Gunning, Pimyupa Manaswiyoungkul

Number of Employees:

1-10

Last Funding Date:

2024-09-05

IPO Status:

Private

Industries: